Skip to content

VISULAS VISULAS combiRecalls & reported problems

Carl Zeiss Meditec AG · VISULAS combi is intended for use in photocoagulating and photodisrupting ocular tissues in the treatment of diseases of the eye, including • Photocoagulation of the retina • Trabeculoplasty • Iridotomy • Posterior capsulotomy • Posterior membranectomy This device is Prescription Use (Rx) only. · Class 2

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04049471091496), received between Nov 14, 2025 and Nov 14, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information1

Patient problems

  • Convulsion/Seizure1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 14, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    IT WAS REPORTED THAT FOLLOWING A LASER TREATMENT WITH THE VISULAS COMBI ON A PATIENT IN CANADA, THE PATIENT APPARENTLY HAD A SEIZURE AND THE CLINIC CALLED A CODE BLUE. THE PATIENT HAS BEEN RELEASED; HOWEVER, NO ADDITIONAL INFORMATION HAS BEEN PROVIDED. NOTE: IN THE CONTEXT OF A HOSPITAL IN CANADA, "CODE BLUE" REFERS TO A MEDICAL EMERGENCY SITUATION WHERE A PATIENT IS EXPERIENCING CARDIAC ARREST OR RESPIRATORY FAILURE AND REQUIRES IMMEDIATE RESUSCITATION. THIS TERM IS PART OF A STANDARDIZED SET OF EMERGENCY CODES USED IN HOSPITALS TO QUICKLY COMMUNICATE SPECIFIC TYPES OF EMERGENCIES TO STAFF.

    Patient problems: Convulsion/Seizure

    MAUDE report 23560960 ↗

Other Laser, Ophthalmic devices

All Laser, Ophthalmic devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.